...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents
【24h】

Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents

机译:利奈唑胺新型氮杂螺环类似物作为抗菌和抗结核药的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

The design, synthesis and antimicrobial evaluation of a novel series of azaspiro analogues of linezolid (1) have been described. Linezolid comprises of a morpholine ring which is known for its metabolism related liabilities. Therefore, the key modification made in the linezolid structure was the replacement of morpholine moiety with its bioisostere, 2-oxa-6-azaspiro[3.3]heptane. Furthermore, the replacement of N-acetyl terminal of 1 with various aromatic or aliphatic functionalities was carried out. The title compounds were evaluated against a panel of Gram-positive and Gram-negative bacteria and Mycobacterium tuberculosis. Subsequent structure-activity relationship (SAR) studies identified several compounds with mixed antibacterial and antitubercular profiles. Compound 22 (IC50 0.72, 0.51, 0.88, 0.49 mu g/mL for Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, respectively) exhibited similar antibacterial profile as I. The N-acetyl derivative 18 was similar to 1 in antitubercular profile. Thus, the present study successfully demonstrated the use of azaspiro substructure in the medicinal chemistry of antibacterial and antitubercular agents. (C) 2016 Elsevier Masson SAS. All rights reserved.
机译:已经描述了利奈唑胺(1)的一系列新的氮杂氮杂螺类似物的设计,合成和抗菌评估。利奈唑胺由吗啉环组成,该环以其代谢相关的负债而闻名。因此,在利奈唑胺结构中进行的关键修饰是用其生物等排物2-oxa-6-azaspiro [3.3]庚烷取代吗啉部分。此外,用各种芳族或脂族官能团代替了1的N-乙酰基末端。针对一组革兰氏阳性和革兰氏阴性细菌和结核分枝杆菌评估标题化合物。随后的结构活性关系(SAR)研究确定了几种具有混合抗菌和抗结核特性的化合物。化合物22(对于大肠杆菌,铜绿假单胞菌,金黄色葡萄球菌,枯草芽孢杆菌分别的IC50为0.72、0.51、0.88、0.49μg / mL)显示出与I类似的抗菌谱.N-乙酰基衍生物18的抗结核谱与1相似。 。因此,本研究成功地证明了氮杂螺环亚结构在抗菌和抗结核药的药物化学中的用途。 (C)2016 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号